314 related articles for article (PubMed ID: 33728582)
1. Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer.
Drill M; Jones NC; Hunn M; O'Brien TJ; Monif M
Purinergic Signal; 2021 Jun; 17(2):215-227. PubMed ID: 33728582
[TBL] [Abstract][Full Text] [Related]
2. Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.
Scarpellino G; Genova T; Munaron L
Recent Pat Anticancer Drug Discov; 2019; 14(1):32-38. PubMed ID: 30652649
[TBL] [Abstract][Full Text] [Related]
3. P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomas.
Kan LK; Seneviratne S; Drummond KJ; Williams DA; O'Brien TJ; Monif M
Purinergic Signal; 2020 Sep; 16(3):327-336. PubMed ID: 32583309
[TBL] [Abstract][Full Text] [Related]
4. P2X7 receptor antagonists: a patent review (2010-2015).
Park JH; Kim YC
Expert Opin Ther Pat; 2017 Mar; 27(3):257-267. PubMed ID: 27724045
[TBL] [Abstract][Full Text] [Related]
5. Roles of purinergic P2X
McLarnon JG
Cancer Lett; 2017 Aug; 402():93-99. PubMed ID: 28536012
[TBL] [Abstract][Full Text] [Related]
6. P2X7 receptor: a critical regulator and potential target for breast cancer.
Zhu X; Li Q; Song W; Peng X; Zhao R
J Mol Med (Berl); 2021 Mar; 99(3):349-358. PubMed ID: 33486566
[TBL] [Abstract][Full Text] [Related]
7. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells.
Di Virgilio F; Jiang LH; Roger S; Falzoni S; Sarti AC; Vultaggio-Poma V; Chiozzi P; Adinolfi E
Methods Enzymol; 2019; 629():115-150. PubMed ID: 31727237
[TBL] [Abstract][Full Text] [Related]
8. P2X7 Purinergic Receptor Is Involved in the Pathophysiology of Mania: a Preclinical Study.
Gubert C; Andrejew R; Leite CE; Moritz CEJ; Scholl J; Figueiro F; Kapczinski F; da Silva Magalhães PV; Battastini AMO
Mol Neurobiol; 2020 Mar; 57(3):1347-1360. PubMed ID: 31729632
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in the Development of Antidepressants Targeting the Purinergic P2X7 Receptor.
Lee S; Ha H; Jang J; Byun Y
Curr Med Chem; 2023; 30(2):164-177. PubMed ID: 35770396
[TBL] [Abstract][Full Text] [Related]
10. Purinergic P2X7 receptor as a potential therapeutic target in depression.
Qi W; Jin X; Guan W
Biochem Pharmacol; 2024 Jan; 219():115959. PubMed ID: 38052270
[TBL] [Abstract][Full Text] [Related]
11. Research Progress in the Relationship Between P2X7R and Cervical Cancer.
Tang Y; Qiao C; Li Q; Zhu X; Zhao R; Peng X
Reprod Sci; 2023 Mar; 30(3):823-834. PubMed ID: 35799022
[TBL] [Abstract][Full Text] [Related]
12. The P2X7 receptor: A main player in inflammation.
Adinolfi E; Giuliani AL; De Marchi E; Pegoraro A; Orioli E; Di Virgilio F
Biochem Pharmacol; 2018 May; 151():234-244. PubMed ID: 29288626
[TBL] [Abstract][Full Text] [Related]
13. P2X7 receptors in neurohypophysial terminals: evidence for their role in arginine-vasopressin secretion.
Cuadra AE; Custer EE; Bosworth EL; Lemos JR
J Cell Physiol; 2014 Mar; 229(3):333-42. PubMed ID: 24037803
[TBL] [Abstract][Full Text] [Related]
14. Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors.
Yue N; Huang H; Zhu X; Han Q; Wang Y; Li B; Liu Q; Wu G; Zhang Y; Yu J
J Neuroinflammation; 2017 May; 14(1):102. PubMed ID: 28486969
[TBL] [Abstract][Full Text] [Related]
15. Lidocaine preferentially inhibits the function of purinergic P2X7 receptors expressed in Xenopus oocytes.
Okura D; Horishita T; Ueno S; Yanagihara N; Sudo Y; Uezono Y; Minami T; Kawasaki T; Sata T
Anesth Analg; 2015 Mar; 120(3):597-605. PubMed ID: 25695577
[TBL] [Abstract][Full Text] [Related]
16. Mapping the Site of Action of Human P2X7 Receptor Antagonists AZ11645373, Brilliant Blue G, KN-62, Calmidazolium, and ZINC58368839 to the Intersubunit Allosteric Pocket.
Bin Dayel A; Evans RJ; Schmid R
Mol Pharmacol; 2019 Sep; 96(3):355-363. PubMed ID: 31263019
[TBL] [Abstract][Full Text] [Related]
17. Purinergic P2X7 receptor antagonist ameliorates intestinal inflammation in postoperative ileus.
Kimura H; Yamazaki T; Mihara T; Kaji N; Kishi K; Hori M
J Vet Med Sci; 2022 Apr; 84(4):610-617. PubMed ID: 35249909
[TBL] [Abstract][Full Text] [Related]
18. P2X7 receptor deletion suppresses γ-radiation-induced hyposalivation.
Gilman KE; Camden JM; Klein RR; Zhang Q; Weisman GA; Limesand KH
Am J Physiol Regul Integr Comp Physiol; 2019 May; 316(5):R687-R696. PubMed ID: 30892913
[TBL] [Abstract][Full Text] [Related]
19. P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy.
Khalafalla MG; Woods LT; Camden JM; Khan AA; Limesand KH; Petris MJ; Erb L; Weisman GA
J Biol Chem; 2017 Oct; 292(40):16626-16637. PubMed ID: 28798231
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel P2X7R antagonists by using structure-based virtual screening and cell-based assays.
Zhao Y; Chen X; Lyu S; Ding Z; Wu Y; Gao Y; Du J
Chem Biol Drug Des; 2021 Jul; 98(1):192-205. PubMed ID: 33993620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]